MediWound Is A Buy Opportunity On The Dip
2025-09-02 05:42:32 ET
Opportunity is Knocking
MediWound Ltd. ( MDWD ) is a stock that proves the adage that obscurity is the worst place to be. Investors are often attracted to biomed startups. MDWD shares topped $41 each in 2021. Interest waned as R&D and clinical trials dragged on. The stock dropped to below $8 but scratched its way back to ~ $20 over the last two years. We rated the stock a buy opportunity last October; we bought shares when it dipped below $17 last week despite a new Seeking Alpha alert warning and a drop in its Quant Rating to strong sell following more than two years of buy and hold assessments. Fewer than 8 analysts regularly follow the stock, adding to the obscurity characterization . ...
Read the full article on Seeking Alpha
For further details see:
MediWound Is A Buy Opportunity On The Dip
NASDAQ: MDWD
MDWD Trading
-0.9% G/L:
$16.575 Last:
12,525 Volume:
$16.59 Open:
